Based on the forecasted data, the antihypertensive medicine use in Australia will see steady incremental growth from 2024 to 2028:
- 2024: 10.5 Units
- 2025: 10.7 Units (Year-on-Year Variation: +1.90%)
- 2026: 10.9 Units (Year-on-Year Variation: +1.87%)
- 2027: 11.0 Units (Year-on-Year Variation: +0.92%)
- 2028: 11.1 Units (Year-on-Year Variation: +0.91%)
The Compound Annual Growth Rate (CAGR) over the next five years (2024-2028) is expected to be approximately 1.43%.
Future Trends
Future trends to watch include advancements in hypertension treatments, an increase in the aging population, and government health initiatives which may contribute to higher consumption rates of antihypertensive medicines.
